ECRIN hosted a staff exchange as part of the RItrain project from 22 to 23 November 2018 in Paris. 

Increasing demand and the use of high-quality samples, data and services place biobanks at the centre of basic and applied research.

ECRIN participated in the “2018 KoNECT-MFDS International Conference” in Seoul, Korea, from October 31st to November 2nd. 

Rome, Italy, 31 October, 2018.

The International Consortium for Personalised Medicine, ICPerMed, publishes today the pre-announcement of their second “BEST PRACTICE IN PERSONALISED MEDICINE" RECOGNITION 2019.

ECRIN's Alicja Szofer-Araya is featured in a short video on the Executive Master in Management of Research Infrastructures (EMMRI).

Open Call for Vaccine Development Services

Press Release

The Coordinated Research Infrastructures Building Enduring Life-science Services (CORBEL) project held its Annual General Meeting from 16 to 17 October in Paris.  

The CORBEL Medical Infrastructure/ Users Forum (MIUF) held its third annual meeting in Paris on 15 October 2018. 

The fourth MiRoR training event took place from 3 to 5 October 2018 in Split, Croatia.

BBMRI-ERIC, EATRIS and ECRIN have released a joint statement on Horizon Europe. 

In their joint paper, they identify four critical success factors for optimal outcomes in the next funding period with regard to the upcoming Horizon Europe framework programme:

The Paediatric Conference “Better Medicines for Children” is an a

IDIBAPS has recently launched the 2^nd international peer-reviewed BITRECS call

Are you involved in developing Equality & Diversity practices for or within a Research Infrastructure? Registrations are open for the RItrain Workshop on Equality, Diversity & Inclusion hosted by EMBL-European Bioinformatics Institute, 29-30 October 2018.

Innovative Global Data-Sharing Platform Vivli Launches with 2,500 Clinical Studies from 15 organizations with data from more than 98 countries across numerous disease areas, including diabetes, Alzheimer’s and malaria, and representing the contributions of more than 1.3 million trial participants